Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients
The immune monitoring of T-cell subpopulations in patients with CSU starting omalizumab, may be a useful strategy to analyze treatment response in the clinical practice.
Authors
- Cristina López (ORCID: https://orcid.org/0000-0001-6644-1659)
- Yanina Jurgens
- Eva Martínez‐Cáceres (ORCID: https://orcid.org/0000-0002-6762-8025)
- Bibiana Quirant‐Sánchez (ORCID: https://orcid.org/0000-0002-3875-8074)
- Aina Teniente‐Serra (ORCID: https://orcid.org/0000-0003-3440-804X)
- Isabel Bielsa (ORCID: https://orcid.org/0000-0001-7978-6111)
- Nathalie Depreux (ORCID: https://orcid.org/0000-0003-2186-2059)
- S agrave nchez-Marr egrave Miquel
- Clara Padró (ORCID: https://orcid.org/0000-0003-0139-5836)
- María Basagaña (ORCID: https://orcid.org/0000-0002-5478-5945)
- Albert Roger
Institutions
- Universitat Autònoma de Barcelona (ES)
- Hospital Universitari Germans Trias i Pujol (ES)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-08-20
- DOI
- https://doi.org/10.3389/fimmu.2024.1413233
- Citations
- 3
- Primary Topic
- Urticaria and Related Conditions
- Type
- article
- Field-Weighted Citation Impact
- 1.41
Funders
- Generalitat de Catalunya
- Agència de Gestió d'Ajuts Universitaris i de Recerca